CHE Stock Analysis: Buy, Sell, or Hold?
CHE - Chemed Corporation
$540.57
5.69 (1.06%)
â˛
5d:
+1.44%
30d:
+7.47%
90d:
+22.43%
WAIT
LOW Confidence
Analysis Updated: Aug 21, 2026 12:00 AM ET
Earnings: Jul 28, 2026
0d
Get Alerted When CHE Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
âšī¸ NEUTRAL: CHE is fairly priced but lacks strong directional signals. At 5.3% expected growth, valuation appears stretched. Wait for clearer setup or better entry on dips.
âšī¸ NEUTRAL: CHE is fairly priced but lacks strong directional signals. At 5.3% expected growth, valuation appears stretched. Wait for clearer setup or better entry on dips.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$615.66
Based on 5.9% avg growth
INTRINSIC VALUE TODAY
$382.28
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 16.8x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: CHE is currently trading at $540.57, which is considered slightly high relative to its 30-day fair value range of $512.79 to $544.42. From a valuation perspective, the stock is trading at a premium (Forward PE: 19.6) compared to its historical average (16.8). At these levels, the market is pricing in 5.3% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, CHE is in a strong uptrend. Immediate support is located at $520.68, while resistance sits at $557.00.
Market Sentiment: The stock scores a mixed 52/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, CHE is in a strong uptrend. Immediate support is located at $520.68, while resistance sits at $557.00.
Market Sentiment: The stock scores a mixed 52/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Historical Trading Range
$512.79 -
$544.42
Company Quality Score
48/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
59.5%
All Signals
- NEUTRAL: Mixed technical signals (52/100)
- BULLISH: High volume confirmation
- NEUTRAL: Near Wall St target ($552.00)
- NEUTRAL: Trading at premium valuation - market expects 5.3% growth which is achievable
- WARNING: Composite score 48/100 in the bottom quintile â this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$512.79 -
$544.42
Current vs Trading Range
SLIGHTLY HIGH
Support & Resistance Levels
Support Level
$520.68
Resistance Level
$557.00
Current Trend
Strong Uptrend
Technical data as of
Aug 21, 2026
Fundamental Context
Forward P/E (Next Year Est.)
19.64
Wall Street Target
$552.00
(+2.1%)
Revenue Growth (YoY)
8.8%
Earnings Growth (YoY)
43.7%
Profit Margin
10.6%
Valuation Premium vs History
+5.3% premium
PE vs Historical
19.6 vs 16.8
STRETCHED
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+5.3%
(market-implied from PE analysis)
1-Year Target
$569.22
(+5%)
2-Year Target
$599.39
(+11%)
3-Year Target
$631.16
(+17%)
3-Yr Target (if PE normalizes)
(PE: 20â17)
PE COMPRESSION
$539.91
(0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 20.1, Growth: 7.8%)
$692.93
(+28%)
Base:
(SPY PE: 19.6, Growth: 7.8%)
$678.05
(+25%)
Bear:
(PE: 16.7, Growth: 7.8%)
$576.35
(+7%)
đ
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (27x PE), but valuation improves significantly next year (20x PE) as earnings recover.
Trailing PE: 26.96 | Current EPS (TTM): $19.84
Bull Case
$816.27
(+51%)
Analyst growth 38.7%, PE expands to 29.7
Base Case
$742.07
(+37%)
Market implied 38.7%, PE stable at 27.0
Bear Case
$363.72
(-33%)
Severe decline -20.0%, PE contracts to 22.9
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share & Embed Analysis
Last updated: August 24, 2026 12:39 AM ET
Data refreshes hourly during market hours. Next update: 1:39 AM
Data refreshes hourly during market hours. Next update: 1:39 AM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CHE showing a specific setup today?
Insider Activity (6 Months)
0
Buys
1
Sells
Net
INSIDERS SELLING
Recent Transactions
Kevin J Mcnamara
SELL
2000 shares
2026-03-12
Top Rated Medical Care Facilities Stocks
Top-rated stocks in Medical Care Facilities by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
THC
Tenet Healthcare CorporaâĻ |
STRONG BUY
22 analysts |
$282 | 37 SELL |
|
HCA
HCA Healthcare, Inc. |
BUY
25 analysts |
$451 | 44 HOLD |
|
CMPS
Compass Pathways Plc |
STRONG BUY
11 analysts |
$24 | 47 HOLD |
|
EHC
Encompass Health Corp |
STRONG BUY
12 analysts |
$148 | 42 HOLD |
|
ADUS
Addus HomeCare CorporatiâĻ |
STRONG BUY
11 analysts |
$135 | 54 HOLD |